Alyeska Investment Group L.P. 13D and 13G filings for Kiora Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:35 pm Purchase | 2026-03-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Alyeska Investment Group L.P. | 394,668 9.990% | 319,040 (+421.85%) | Filing |
| 2025-02-14 4:25 pm Sale | 2024-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Alyeska Investment Group L.P. | 75,628 2.500% | -180,780 (-70.50%) | Filing |
| 2024-11-14 4:32 pm Purchase | 2024-09-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | Alyeska Investment Group L.P. | 256,408 8.400% | 256,408 (New Position) | Filing |